Nucleix's Grant

Nucleix raised a round of funding on January 15, 2016. Investors include Horizon 2020.

Nucleix develops, manufactures and markets non-invasive molecular cancer diagnostic tests. The company's sensitive and specific tests are based on identification of subtle changes in methylation patte…

Articles about Nucleix's Grant: